Open AccessThe clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial
Author(s) -
Mike Crawford,
Verity C. Leeson,
Rachel Evans,
Barbara Barrett,
Aisling McQuaid,
Jack Cheshire,
Rahil Sanatinia,
Gary Lamph,
Piyal Sen,
Katina Anagnostakis,
Louise A C Millard,
Inti Qurashi,
Fintan Larkin,
Nusrat Husain,
Paul Moran,
Thomas R. E. Barnes,
Carol Paton,
Zoë Hoare,
Marco Picchioni,
Simon Gibbon
Publication year - 2022
Publication title -
therapeutic advances in psychopharmacology
Language(s) - English
Resource type - Journals
eISSN - 2045-1261
pISSN - 2045-1253
DOI - 10.1177/20451253221090832
Subject(s) - placebo , borderline personality disorder , clozapine , medicine , adverse effect , randomized controlled trial , psychiatry , schizophrenia (object oriented programming) , physical therapy , alternative medicine , pathology